GlobeNewswire Inc.··NaTrinity Biotech Faces Nasdaq Delisting Risk Over Minimum Price Compliance
Trinity Biotech received a Nasdaq delisting warning after failing to maintain the $1.00 minimum bid price. The company has until August 2026 to restore compliance or face delisting.
TRIBbiotechnologystock price